RE:RE:RE:Just imagine We should never forget that EXAS:US is selling a much more expansive ($600) and much more complicated poop test.
Given time blood Tests will catch on, and that is what SZLS is working on right now with the Big HealthCare Systems.
In the PressRelease Aug 14, 2019 SZLS said (QUOTE) " SZLS closed a $3.7 million private placement to expand its commercial footprint in the US and abroad (END OF QUOTE).
You can add $1.5 million from Warrants and Options.
A total of almost $5 million to promote a Blood Test versus a poop test.
I challenge you to find a single patient that will prefer to pay $600 to poop in a box, versus $300 to give a blood sample.
Given time SZLS Blood Test will catch on , and it won't cost $10 million a year to convince patients to take it.
That is the main reason that Big HealthCare Systems, are at this very moment negotiating with SZLS , these Big HealthCare Systems understood that the future of cancer testing is in early detection blood cancer tests not in poop tests.
capebretongirl wrote: frewil11 wrote: To get this out to the public in the masses it costs tens of millions of dollars in marketing costs even hundreds , so the onty way this company makes it is if they intregate their tech with a large health insurance company , it is a complete shame in how the system could pass this great science by because of SZLS not having this kind of money or backing.
Yes, the curse of any penny stock - money or lack of it! We do have a large health insurer in tow so lets hope that does the trick - even small concerns like Coastal Medical can help spread the word. Ultimately though, you can't beat the impact of a direct marketing campaign costing tens of millions to get the work out there - we do have some challenges.